Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravinay Bhindi

Showing results (191-200 of 224) with videos related to

Pageof 23
Sort By:
JACC. Cardiovascular Interventions|April 7, 2018
The Presence of a CTO in a Non-Infarct-Related Artery During a STEMI Treated With Contemporary Primary PCI Is Associated With Increased Rates of Early and Late Cardiovascular Morbidity and Mortality: The CTO-TOTAL SubstudyUsaid K Allahwala, Sanjit S Jolly, Vladimír Džavík, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2022
Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial InfarctionStephen T Vernon, Katharine A Kott, Thomas Hansen, et al.
Science Advances|May 13, 2026
Preemptive cardioprotection with a small molecule in rodents that suppresses genes predictive of heart failureYue Li, Matthew V Andrews, David T Humphreys, et al.
European Heart Journal|May 22, 2015
Culprit lesion thrombus burden after manual thrombectomy or percutaneous coronary intervention-alone in ST-segment elevation myocardial infarction: the optical coherence tomography sub-study of the TOTAL (ThrOmbecTomy versus PCI ALone) trialRavinay Bhindi, Olli A Kajander, Sanjit S Jolly, et al.
American Heart Journal|March 1, 2014
Design and rationale of the TOTAL trial: a randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCISanjit S Jolly, John Cairns, Salim Yusuf, et al.
The Medical Journal of Australia|August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statementSarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
Circulation|September 1, 2020
Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical TrialDavid C Tong, Stephen Quinn, Arthur Nasis, et al.
Circulation|May 9, 2022
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical TrialClara K Chow, Harry Klimis, Aravinda Thiagalingam, et al.
BMJ Open|January 29, 2018
TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocolClara K Chow, Aravinda Thiagalingam, Karla Santo, et al.
European Heart Journal. Acute Cardiovascular Care|March 24, 2021
Novel device-based therapies to improve outcome in ST-segment elevation myocardial infarctionGiovanni Luigi De Maria, Hector M Garcia-Garcia, Roberto Scarsini, et al.
Pageof 23

Showing results (191-200 of 224) with videos related to

Sort By:
Pageof 23
JACC. Cardiovascular Interventions|April 7, 2018
The Presence of a CTO in a Non-Infarct-Related Artery During a STEMI Treated With Contemporary Primary PCI Is Associated With Increased Rates of Early and Late Cardiovascular Morbidity and Mortality: The CTO-TOTAL SubstudyUsaid K Allahwala, Sanjit S Jolly, Vladimír Džavík, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2022
Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial InfarctionStephen T Vernon, Katharine A Kott, Thomas Hansen, et al.
Science Advances|May 13, 2026
Preemptive cardioprotection with a small molecule in rodents that suppresses genes predictive of heart failureYue Li, Matthew V Andrews, David T Humphreys, et al.
European Heart Journal|May 22, 2015
Culprit lesion thrombus burden after manual thrombectomy or percutaneous coronary intervention-alone in ST-segment elevation myocardial infarction: the optical coherence tomography sub-study of the TOTAL (ThrOmbecTomy versus PCI ALone) trialRavinay Bhindi, Olli A Kajander, Sanjit S Jolly, et al.
American Heart Journal|March 1, 2014
Design and rationale of the TOTAL trial: a randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCISanjit S Jolly, John Cairns, Salim Yusuf, et al.
The Medical Journal of Australia|August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statementSarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
Circulation|September 1, 2020
Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical TrialDavid C Tong, Stephen Quinn, Arthur Nasis, et al.
Circulation|May 9, 2022
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical TrialClara K Chow, Harry Klimis, Aravinda Thiagalingam, et al.
BMJ Open|January 29, 2018
TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocolClara K Chow, Aravinda Thiagalingam, Karla Santo, et al.
European Heart Journal. Acute Cardiovascular Care|March 24, 2021
Novel device-based therapies to improve outcome in ST-segment elevation myocardial infarctionGiovanni Luigi De Maria, Hector M Garcia-Garcia, Roberto Scarsini, et al.
Pageof 23